Related by context. All words. (Click for frequent words.) 76 EnVivo Pharmaceuticals Inc. 73 Agios Pharmaceuticals 72 FoldRx Pharmaceuticals Inc. 72 Ceregene 71 Enanta Pharmaceuticals 70 Merrimack Pharmaceuticals 70 EnVivo 70 Alvine Pharmaceuticals 68 Regado Biosciences 68 PsychoGenics 68 FORMA Therapeutics 68 Ascenta Therapeutics 68 Genaera Corporation 67 Bayhill Therapeutics 67 novel peptides 67 Receptos 67 Marinus Pharmaceuticals 67 Locus Pharmaceuticals 67 KAI Pharmaceuticals 67 Arno Therapeutics 67 Nereus Pharmaceuticals 67 Archemix Corp. 67 Cascade LifeSciences 67 FoldRx 67 Syndax 67 Avila Therapeutics 67 VisEn Medical 67 Creabilis Therapeutics 67 Elixir Pharmaceuticals 67 Sopherion Therapeutics 66 Intarcia 66 Amarantus 66 Marillion Pharmaceuticals 66 Idera Pharmaceuticals 66 Melior Discovery 66 Robert L. Bratzler 66 Pfizer Regenerative Medicine 66 Immunex Corporation 66 Regulus Therapeutics 66 Vaccinex 66 Alder Biopharmaceuticals 66 Amira Pharmaceuticals 66 Quark Pharmaceuticals 66 Epizyme 66 Altair Therapeutics 66 Genocea Biosciences 66 InNexus Biotechnology 66 Galenea 66 Hybridon 66 pralatrexate injection folate analogue 66 IRX Therapeutics 66 Jean Pierre Sommadossi Ph.D. 65 Adenosine Therapeutics 65 Trophos 65 VasoGenix Pharmaceuticals 65 Quark Biotech 65 Ophthotech 65 Nicholas Nicolaides 65 Inotek 65 TargeGen 65 glucokinase activator 65 Infinity Pharmaceuticals 65 Semafore 65 Pervasis 65 Epiphany Biosciences 65 Singulex 65 Surface Logix 65 Pervasis Therapeutics Inc. 65 AMEX RGN 65 GENFIT 65 FOLOTYN ® 65 PharmaNova 65 Acceleron Pharma 65 Nuon Therapeutics 65 nicotinic alpha 7 65 MKC# MKC# PP 65 Hoyoung Huh 65 Cylene Pharmaceuticals 65 ActivX 65 Raven Biotechnologies 65 Alnylam Pharmaceuticals 65 VentiRx 65 OncoMed Pharmaceuticals 65 Celladon Corporation 65 Cara Therapeutics 65 Relypsa 65 Helicon Therapeutics 65 Gemin X 64 gastro intestinal inflammation 64 REGENERX BIOPHARMACEUTICALS INC. 64 Elusys Therapeutics 64 NormOxys 64 Coley Pharmaceutical Group 64 Predix Pharmaceuticals 64 Alligator Bioscience AB 64 Initiates Clinical Trial 64 Biodesix 64 Christoph Westphal MD Ph.D. 64 Kazumi Shiosaki 64 GlycoMimetics 64 OTCBB PYTO 64 Logical Therapeutics 64 Ambit Biosciences 64 Anaphore 64 miRagen 64 kidney urologic 64 TESARO 64 targeted radiotherapeutic 64 Catalyst Biosciences 64 Preclinical Development 64 miRagen Therapeutics 64 Psyadon Pharmaceuticals 64 Seaside Therapeutics 64 ERYtech 64 Repligen Corporation 64 Exploit collaboration 64 Celator 64 Tikvah Therapeutics 64 NPC 1C 64 Conatus Pharmaceuticals 64 Ph.D. Targacept 64 Genome Therapeutics 64 AVEO Pharmaceuticals 64 LEAD Therapeutics 64 Kleanthis G. Xanthopoulos Ph.D. 64 Addrenex Pharmaceuticals 64 ImmuneRegen BioSciences 64 Neurome 64 Syndax Pharmaceuticals 64 Velcura Therapeutics 64 ALTROPANE R 64 Corixa Corporation 64 Epitomics 64 Howard Fillit MD 64 JJ Finkelstein 64 CeNeRx BioPharma 64 Aileron Therapeutics 64 novel anti infective 64 Immunotherapeutic 64 FluoroPharma 64 Cellerant Therapeutics 64 Biomarker Study 64 Antibody Drug Conjugate 64 Aegera 64 EyeGate Pharma 63 Emisphere Technologies 63 TransMolecular 63 Quark Biotech Inc. 63 NASDAQ LGND 63 ImQuest 63 romazarit 63 Cequent Pharmaceuticals 63 Aerovance 63 Angiocept 63 Cerimon 63 Immune Tolerance Network 63 oncolytic virus therapies 63 Excaliard 63 anticancer therapeutics 63 Tod Woolf Ph.D. 63 Reata Pharmaceuticals 63 Memgen 63 Lycera 63 mGluR2 NAM 63 Peptimmune 63 Idun Pharmaceuticals 63 Nasdaq RXII 63 Antibody Therapeutics 63 Curemark 63 NovaBay Pharmaceuticals 63 Ercole Biotech 63 Cerenis Therapeutics 63 Ception Therapeutics 63 Avicena 63 VIA Pharmaceuticals 63 Alseres Pharmaceuticals Inc. 63 Neogenix Oncology 63 Uli Hacksell Ph.D. 63 BioAxone 63 Virion Systems 63 Cenix BioScience 63 CRACM 63 Arisaph Pharmaceuticals 63 Idenix Pharmaceuticals 63 Alexis Borisy President 63 Biomodels 63 OTCBB AOLS 63 Aflibercept 63 sirtuin inhibitor program 63 Initiates Clinical 63 Dicerna 63 GVAX ® 63 DiaKine Therapeutics 63 CureDM 63 FASgen 63 Amplimmune 63 Metabasis Therapeutics Inc. 63 Pharmion Corporation 63 Preclinical Study 63 Traversa Therapeutics 63 Wellstat 63 Ironwood Pharmaceuticals 63 Dr. Masamichi Koike 63 Kosan dependence 63 THR beta agonist 63 Tacere 63 OTCBB PYTO FWB ET6 63 Applied NeuroSolutions 63 Athenagen 63 Chemokine Therapeutics 63 Zafgen 63 Cempra Pharmaceuticals 63 Phytomedics Inc. 63 NASDAQ INFI 63 therapeutic monoclonal antibody 63 Therion Biologics Corporation 63 Inc. OTCBB CYKN 63 Etubics 63 adrenergic regulation 63 Halozyme Therapeutics 63 Teplizumab 63 ZFP Therapeutics 63 Immunotope 63 Therion Biologics 63 Semafore Pharmaceuticals 63 Coronado Biosciences 63 Paul Laikind 63 Resolvyx Pharmaceuticals 63 Enzo Therapeutics 62 Alton Boynton 62 Nanotherapeutics 62 Squalamine 62 Eckard Weber 62 AVEO Pharmaceuticals Inc. 62 Curaxin 62 Nanobac Pharmaceuticals 62 selective androgen receptor modulators 62 mGluR4 62 ImmuneRegen BioSciences Inc. 62 deCODE chemistry 62 Ore Pharmaceuticals 62 QuatRx 62 iZumi Bio 62 Profectus BioSciences 62 Compendia Bioscience 62 Ambrx 62 Calistoga Pharmaceuticals 62 CHDI Foundation 62 Anchor Therapeutics 62 Euronext Amsterdam GLPGA 62 Phase 1b clinical trials 62 Tuan Ha Ngoc 62 SANOFI AVENTIS 62 non nucleoside inhibitor 62 Edward Lanphier Sangamo 62 Nasdaq ALNY 62 Forma Therapeutics 62 t2cure GmbH 62 Viamet Pharmaceuticals 62 OMP #R# 62 Protein Polymer Technologies 62 Plexxikon proprietary 62 Pervasis Therapeutics 62 Virdante 62 Metabolic Disease 62 Selecta Biosciences 62 Array BioPharma 62 MassGeneral Institute 62 Nanobody ® 62 Chronogen 62 CK # novel 62 AmpliMed 62 Adolor Corporation 62 CYT# potent vascular disrupting 62 Stromedix 62 Taligen Therapeutics 62 Daclizumab 62 Brussels THR 62 Mirna Therapeutics 62 Phase 2b Clinical Trial 62 Cerimon Pharmaceuticals Inc. 62 HepaLife Technologies Inc. 62 OMRIX Biopharmaceuticals Inc. 62 Cardioxyl 62 Locked Nucleic Acid 62 RhuDex 62 Nuvera Biosciences 62 Angiochem 62 Mersana Therapeutics Inc. 62 engineered RAP peptides 62 Enzon Pharmaceuticals 62 Neil K. Warma 62 Ceflatonin R 62 Charlesson 62 Protexia ® 62 OncoMed 62 Xencor 62 IMC #B 62 HuLuc# 62 Daniel Von Hoff 62 Xytis 62 Cenomed 62 Inc. Nasdaq IMGN 62 Alnara Pharmaceuticals 62 Saegis Pharmaceuticals 62 AMEX REX 62 Initiates Enrollment 62 PEG SN# 62 AviaraDx 62 MacroGenics 62 Archexin 62 Dr. Boro Dropulic 62 Teikoku Pharma USA 62 Corautus Genetics 62 Lankenau Institute 62 SuperAntibody 62 MEK inhibitor 62 PRNewswire FirstCall Neurogen 62 EPIX Pharmaceuticals Inc. 62 Daniel Junius 62 activate SIRT1 62 Biogen Idec NASDAQ BIIB 62 Ascent Therapeutics 62 Neuroptix 62 Alnylam Nasdaq ALNY 62 Kathleen Danenberg 62 TRACON Pharmaceuticals 62 CoMentis 62 Omeros Corporation 62 AKIP ™ 62 Mersana 62 Experimental Therapeutics Program 62 Odyssey Thera 62 PhytoMedical Technologies Inc. 62 Juvaris BioTherapeutics 62 R#/MEM 62 antisense inhibitors 62 Alseres Pharmaceuticals 62 novel therapeutic antibodies 62 OTCBB EMIS 62 Velcura 62 JAK2 Inhibitor 62 tubulin inhibitor 62 Verastem 62 Tibotec BVBA 62 NASDAQ ISIS 62 Synta Pharmaceuticals 62 KineMed 62 Ocular Therapeutix 62 MultiCell Technologies 62 Neurogen Corporation 62 CardioVascular BioTherapeutics 62 Hydra Biosciences 62 non nucleoside HCV 62 Aphton Corporation 62 Joshua Boger Ph.D. 62 Afferent Pharmaceuticals 61 Nasdaq IDRA 61 Maxine Gowen Ph.D. 61 HistoRx 61 Vitae Pharmaceuticals 61 IAP inhibitors 61 Syntonix 61 DiscoveRx 61 Sapacitabine 61 XSSE OXGN 61 Taligen 61 George J. Vergis 61 ibudilast 61 Progenics Pharmaceuticals 61 Neotropix 61 Aeolus Pharmaceuticals 61 Avalon Pharmaceuticals 61 rxRNA 61 PDE# inhibitors 61 Knopp Neurosciences 61 acadesine 61 Regeneron Pharma 61 Lexicon Genetics 61 Tobira Therapeutics 61 Posiphen TM 61 M.D. Ph.D. 61 Esperion Therapeutics 61 NASDAQ ALTH biopharmaceutical 61 Resolvyx 61 Aerie Pharmaceuticals 61 Eric von Hofe 61 Syntonix Pharmaceuticals 61 neurology immunology 61 Saladax Biomedical 61 enGene 61 IL# PE#QQR 61 mGluR2 positive 61 molecular chaperone regulation 61 Dicerna Pharmaceuticals Inc. 61 Prolexys 61 NYSE Amex AEN 61 NeoGenesis 61 Nasdaq VRTX 61 NASDAQ CGEN announced 61 Aeolus Pharmaceuticals Announces 61 Mersana Therapeutics 61 Intellect Neurosciences 61 PF # [002] 61 Syndax Pharmaceuticals Inc. 61 WHO TDR 61 Phenomix Corporation 61 3 kinase PI3K 61 Aegera Therapeutics 61 Fluxion Biosciences 61 Portola Pharmaceuticals 61 novel antiviral therapeutics 61 VentiRx Pharmaceuticals 61 Xanthus Pharmaceuticals Inc. 61 Neurimmune 61 NanoBio Corporation 61 Cutanea Life Sciences 61 Avera Pharmaceuticals 61 telomerase therapeutic 61 Altus Pharmaceuticals 61 Intellikine 61 Cordex Pharma 61 Proteon Therapeutics 61 ProMune 61 Nasdaq IDRA today 61 Expression Genetics 61 Georges Gemayel 61 Adnexus Therapeutics 61 ISIS Pharmaceuticals 61 novel immunotherapies 61 Onconova 61 CEQ# 61 Lung Rx 61 Amphora Discovery 61 InVasc 61 Source MDx 61 Supernus Pharmaceuticals 61 Cardiokine 61 Amorcyte 61 Novel Antibody 61 Provid Pharmaceuticals 61 Ocera Therapeutics 61 Epeius Biotechnologies Corporation 61 Cellerant 61 Anticancer Agent 61 Promedior 61 QR Pharma 61 Carigent 61 AMEX DDD 61 RegeneRx Biopharmaceuticals Inc. 61 BRNI 61 Quintessence Biosciences 61 Myocet 61 Tranzyme Pharma 61 Abeome 61 KYTHERA Biopharmaceuticals Inc. 61 ABI OTCBB AMAR 61 TRANSDUR ™ 61 Calibrant Biosystems 61 midstage clinical 61 Pfizer Ophthalmics 61 Albugon 61 Paramount BioSciences 61 ARRY # 61 nitric oxide donating 61 Begins Dosing 61 5 HT4 61 Nasdaq CGEN 61 Protalex Inc. 61 Akebia Therapeutics 61 AGY Therapeutics 61 Cardiovascular Therapeutics 61 Omacetaxine 61 Sirtris Pharmaceuticals 61 product platforms AZX# 61 BioLife Solutions 61 Evaluation Program CTEP 61 Vegenics 61 Naurex 61 Nasdaq IDRA biotechnology 61 Peregrine Pharmaceuticals 61 Xcytrin R 61 Satori Pharmaceuticals 61 Tokai Pharmaceuticals 61 immuno inflammatory diseases 61 Reports Preclinical Data 61 FivePrime Therapeutics 61 Aganocide ® 61 William H. Rastetter 61 Zyngenia 61 Nasdaq HALO biopharmaceutical 61 RenaMed 61 Sirion Therapeutics 61 Factor VIIa 61 J. Donald deBethizy 61 NKT Therapeutics 61 IR BioSciences Holdings 61 therapeutic monoclonal antibodies 61 HDL Mimetic Peptide 61 Diatos 61 Eleven Biotherapeutics 61 Nasdaq SGEN 61 Romidepsin 61 Bayer HealthCare Onyx Pharmaceuticals 61 Vaughn M. Kailian 61 Regeneron Pharmaceuticals 61 MT#/MEDI-# 61 NASDAQ AVEO 61 Limerick BioPharma 61 peptidic compound 61 KuDOS 61 AFREZZA TM 61 Presidio Pharmaceuticals 61 CEO Tod Woolf 61 Frankfurt XMP 61 NABTT 61 HQK 61 mertansine 61 Stemgent 61 Personalized Immunotherapy 61 Tolerx 61 investigational pan BCR 61 Dynogen 61 EGEN 61 BLSI 60 adenosine A2A 60 Anthony Giovinazzo 60 Xenon Pharmaceuticals 60 Freedom Meditech 60 CombinatoRx Incorporated 60 Profectus Biosciences 60 MBRX 60 Potelligent Technology 60 molecular imaging radiopharmaceutical 60 Mpex Pharmaceuticals 60 Diffusion Pharmaceuticals 60 Heartscape Technologies 60 OTCBB NRGX 60 ELADUR ™ 60 Nasdaq AGEN 60 H3 Biomedicine 60 Metabasis Therapeutics 60 Trastuzumab DM1 60 Nasdaq CYTR biopharmaceutical 60 Genetic Therapy 60 Barry D. Quart 60 Zelos Therapeutics 60 GSK '# 60 Therapeutic Antibody 60 LifeSpan BioSciences 60 histone deacetylase HDAC inhibitors 60 synthetic retinoid 60 NGFN 60 OTCBB NRGX biotechnology 60 Dr. Kantarjian 60 Salmedix 60 BioNumerik 60 CytomX Therapeutics 60 selective inhibition 60 anti botulism antibody 60 TetraLogic 60 Tapestry Pharmaceuticals 60 Cotara ® 60 Upstream Biosciences 60 Alnylam Biotherapeutics 60 Cancer Immunotherapeutics 60 Novel Therapeutics 60 Kinase Inhibitor 60 AngioChem 60 5 lipoxygenase activating 60 Hepregen 60 Phase #b/#a clinical 60 Safi Bahcall Ph.D. 60 Proacta 60 Gliknik 60 Nasdaq LEXG 60 RNA Therapeutics 60 Phase III Pivotal 60 Nanobiotix 60 alvespimycin 60 cyclophilin inhibitors 60 small molecule thrombopoietin 60 Lexicon Genetics Incorporated 60 TolerRx 60 Nasdaq DVAX 60 miRNA therapeutics 60 NeurAxon Inc. 60 Alzheimer disease cognitive impairment 60 Cardioxyl Pharmaceuticals 60 RNAi Therapeutics 60 Tragara Pharmaceuticals Inc. 60 Solazed TM 60 Myrexis Inc. 60 CyDex Pharmaceuticals Inc. 60 David H. Fater 60 small molecule defensin 60 Sunesis Pharmaceuticals Inc. 60 Urocortin 2 60 Cellective Therapeutics 60 Aptiv Solutions 60 biased ligand 60 ArQule Kinase Inhibitor Platform 60 Commercialize Novel 60 Optivia Biotechnology 60 Panzem R 60 NASDAQ OMX Nordic ACTI 60 Optherion 60 Osiris Therapeutics 60 Combivir Kivexa 60 myasthenia gravis Huntington 60 OTCBB HXBM developer 60 Novel Oral 60 Guanilib 60 oral prodrug 60 Sangamo BioSciences 60 Kevin Rakin 60 small molecule agonists 60 Afferent 60 CD# CEA 60 Inotek Pharmaceuticals Corporation 60 GSK Rare Diseases 60 Hana Biosciences 60 candidate AQ4N 60 NASDAQ EPIX 60 Neuraltus 60 Alethia Biotherapeutics 60 Prof. Pnina Fishman 60 Callisto Pharmaceuticals Inc. 60 Intarcia Therapeutics Inc. 60 Gastrotech 60 personalized cellular immunotherapy 60 Genitope Corporation 60 Fresenius Biotech 60 Sanofi aventis EURONEXT SAN 60 drug pipeline TAFA# 60 novel VDA molecule 60 Ridaforolimus 60 Keryx Biopharmaceuticals Inc. 60 Viron Therapeutics 60 Genstruct 60 cardio renal 60 novel peptide 60 mGluR4 PAM 60 EHT AGN 60 Syrrx 60 ImmunoGen Inc. 60 Homspera TM 60 Neurobiological Technologies 60 Zosano Pharma 60 Affimed Therapeutics AG 60 Small Molecule 60 Tetraphase Pharmaceuticals 60 TRO# 60 Biomarker Discovery 60 StromaCel Inc. 60 Harry Palmin President 60 NYSE Amex PTN 60 Prednisporin 60 Nasdaq IMGN 60 PARI Pharma 60 Awarded Qualifying Therapeutic 60 Lixivaptan 60 Ardea Biosciences 60 Nasdaq NRGN 60 tiapamil 60 InteRNA Technologies 60 IMiDs R 60 Nasdaq HALO 60 Akesis Pharmaceuticals 60 TRAIL receptor antibodies 60 Cerimon Pharmaceuticals 60 Aegis Therapeutics 60 ANAVEX 60 Morria Biopharmaceuticals Plc 60 Ostabolin C TM 60 RxKinetix 60 ProtoKinetix 60 OTCBB IMUC 60 Selventa 60 LSE ASM 60 Neurologix Inc. 60 Alios BioPharma 60 Cempra 60 Cardiac Dimensions 60 Initiates Phase II 60 JAK2 inhibitor 60 ProNAi 60 Inc. AMEX YMI 60 Antisense Pharma GmbH 60 Neogenix 60 IAP inhibitor 60 Namenda Memantine HCl 60 OTCBB CVBT 60 OncoSec 60 Presents Preclinical Data 60 About Positron Positron 60 Versartis 60 Banyan Biomarkers 60 Fovea Pharmaceuticals 60 SinuNase ™ 60 AVANT Immunotherapeutics 60 Receives Orphan Drug 60 OTC BB PVCT 60 Hematological Malignancies 60 ASX PGL 60 Cortex Pharmaceuticals 60 JAK1 60 EVIZON TM 60 Agensys 60 Initiates Phase III 60 Cancer Immunotherapy 60 Addex Pharmaceuticals SWISS ADXN 60 Successfully Completes Phase 60 David Sidransky MD 60 Sunesis Pharmaceuticals 60 Sequella 60 Harold Van Wart 60 Vaccine Adjuvant 60 David Sidransky 60 Auspex Pharmaceuticals 60 drug GAP #B# 60 CardioVascular BioTherapeutics Inc. 60 lixivaptan 60 tramiprosate Alzhemed TM 60 AAG geldanamycin analog 60 Ryuji Ueno 60 NYSE Amex PBTH 60 Revotar 60 Dale Pfost 60 milnacipran HCl 60 Aurora Kinase 60 Phase 2b Trial 60 Metabolex 60 PRNewswire FirstCall Isis Pharmaceuticals 60 Adnectin 59 Decision Biomarkers 59 Oxis International 59 Scynexis 59 HPV cervical dysplasia 59 Proteo 59 purinergic receptors P#X# 59 Bassil Dahiyat Ph.D. 59 Urigen Pharmaceuticals Inc. 59 Steven B. Ratoff 59 Tom van Aken 59 ARIAD Pharmaceuticals 59 Inc. OTCBB VIVK 59 Therapeutic Competitors Companies 59 TACI Ig 59 Acetylon 59 Knopp Biosciences 59 LifeGen 59 Novasys Medical 59 PhotoThera 59 Prometheus Laboratories 59 Urigen Pharmaceuticals 59 Epix Pharmaceuticals 59 TOPICA 59 ThermoDox ® clinical 59 Pimavanserin 59 Nitric Bio 59 Mithridion 59 ZyStor Therapeutics Inc. 59 Affinium Pharmaceuticals 59 NanoViricides 59 Nuclear Receptors 59 Helix BioMedix Inc. 59 Quark Pharmaceuticals Inc. 59 DeveloGen 59 NASDAQ ARRY 59 Craig Tooman 59 Nanobody 59 Pancreate 59 CombinatoRx Incorporated NASDAQ CRXX 59 Aureon Laboratories 59 Novosom 59 Ikaria Holdings Inc. 59 cardiac muscle contractility 59 Nasdaq NPSP 59 Vion Pharmaceuticals 59 Nautilus Biotech 59 Cetrorelix 59 oral ghrelin agonist 59 AVONEX ® 59 Ziopharm 59 Medistem Laboratories 59 Celsion Corporation 59 NOVAVAX 59 Harbor BioSciences 59 C3 Jian 59 Chemokine 59 NASDAQ LIPD 59 Predictive Biosciences 59 Meets Primary Endpoint 59 QuatRx Pharmaceuticals 59 TOPIGEN 59 Lexicon Pharmaceuticals 59 Paratek Pharmaceuticals Inc. 59 Aestus Therapeutics 59 MCSP respectively 59 PrimeGen Biotech 59 Nasdaq RDEA 59 Cambria Biosciences 59 neuropathic pain spasticity 59 ZFNs clinical trials 59 Calando Pharmaceuticals 59 Trofex 59 Inc. Nasdaq INFI 59 JAK3 59 RayBiotech 59 Alnylam Pharmaceuticals Nasdaq ALNY 59 Dr. Fahar Merchant 59 TransPharma 59 POSIDUR TM ELADUR TM 59 YONDELIS R 59 Neutrolin ® 59 Quanterix 59 David Schenkein MD 59 OTCBB IMNR 59 Nasdaq VRTX today 59 Ron Najafi 59 BrainCells Inc. 59 InteKrin 59 NASDAQ CORT 59 Tod Woolf 59 iBIO Institute 59 developer Antisoma plc 59 Volcano Therapeutics 59 SIX RO ROG 59 Sunshine Biopharma 59 Nasdaq IDIX biopharmaceutical 59 GlycArt 59 RNA interference RNAi therapeutics 59 Listeria vaccine 59 Tesmilifene 59 First Patient Enrolled 59 Kosan epothilone program 59 targeting CD# 59 OTCBB CTIX 59 TELINTRA R 59 please visit www.metabolon.com 59 Maxy G# 59 PHX# 59 SEQureDx ™ 59 CCR9 antagonist 59 Haim Aviv 59 novel RNAi therapeutics 59 RECOTHROM ® 59 psoriasis rheumatoid arthritis 59 BioRexis 59 Septin9 biomarker 59 Scaffold Based 59 Apexigen 59 NEUGENE R 59 recombinant biopharmaceutical 59 Affinitak 59 beta secretase inhibitors 59 Molecular Templates 59 TSX VENTURE COT 59 Symadex 59 NYSE Amex RGN 59 DiaKine 59 RegeneRx Biopharmaceuticals 59 Cerus Corporation 59 R#/MEM # 59 VitiGam 59 commercialize apixaban 59 Triton BioSystems 59 selective kinase inhibitor 59 Alexis Borisy 59 Iconix Pharmaceuticals 59 AEG# 59 Oncolin 59 Sunovion Pharmaceuticals Inc. 59 Pacific Biomarkers 59 Sidney Kimmel Cancer 59 PORxin TM 59 Guy Malchi 59 Study ADCS 59 Abbie Celniker Ph.D. 59 Cellzome 59 Dr. Aiping Young 59 FibroGen 59 immatics 59 Power3 Medical 59 Imetelstat 59 ChemoCentryx 59 NYSE Amex YMI 59 NGM Biopharmaceuticals 59 midstage trials 59 Curaxin CBLC# 59 PSMA ADC 59 Numoda 59 Gemin X Biotechnologies 59 Aegerion Pharmaceuticals Inc. 59 Nasdaq PANC 59 YM AIM YMBA 59 ACADIA Pharmaceuticals 59 Advanced Biotherapy 59 Cortria 59 DF HCC 59 TKB# 59 Othera Pharmaceuticals Inc. 59 ActivBiotics 59 Cytokine PharmaSciences 59 Inovio clinical 59 HemaQuest 59 candidate deforolimus 59 Phase IIb clinical trials 59 SciClone Pharmaceuticals 59 Disease IBD 59 Adeona Pharmaceuticals Inc. 59 Panacea Pharmaceuticals 59 beta HSD1 59 PROfusion 59 Autoimmune Disease 59 Selective Electrochemical Tumor Ablation 59 mTOR mammalian target 59 EP #R 59 Liprotamase 59 Isotechnika Pharma 59 Anacor Pharmaceuticals 59 cathepsin K inhibitor 59 attach auristatin 59 Nasdaq ENMD 59 Ligand proprietary 59 Jaiva Technologies 59 Compound Therapeutics 59 iPierian 59 ARYx Therapeutics 59 BioSpecifics Technologies Corp. 59 Receive Milestone Payment 59 Intercept Pharmaceuticals 59 BXT # 59 Marc Tessier Lavigne 59 BellBrook Labs 59 HGS# 59 Maxim Pharmaceuticals 59 cMET 59 ENMD # 59 cosmetic cosmeceutical products 59 CD# monoclonal antibody 59 DNA RNA Medicines 59 TIMI Study Group 59 histone deacetylase inhibitor 59 DiObex 59 histone deacetylase HDAC 59 Xenogen Corporation 59 predictive toxicology 59 KaloBios 59 hypoxia activated prodrug 59 Selecta Biosciences Inc. 59 Cyclacel Pharmaceuticals 59 Completes Patient Enrollment 59 Accentia Biopharmaceuticals 59 Anadys Pharmaceuticals 59 OncoVex 59 Nasdaq FURX 59 CCR5 mAb 59 HTS assay 59 CRMD pharmaceutical 59 ALN PCS 59 Licenses Novel 59 Trellis Bioscience 59 NASDAQ IDRA 59 Dynogen Pharmaceuticals 59 Max Neeman International 59 Ron Bentsur 59 XL# XL# 59 XTLbio 59 KNS # 59 INSPIRE Trial Phase III 59 Panzem 59 Collateral Therapeutics 59 AMEX KAL 59 VIRxSYS 59 PhaseBio 59 Medivation Inc 59 vaccine GRNVAC1 59 AltheaDx 59 HELSINN 59 AkaRx 59 Aegerion Pharmaceuticals 59 multi kinase inhibitor 59 CFFT 59 Veronate R 59 Kirsten Drejer 59 Elazer Edelman 59 Neurologix 59 Provectus Pharmaceuticals specializes 59 ALN TTR 59 TNFerade TM 59 anti CD3 monoclonal 59 ospemifene 59 YONDELIS 59 Comprehensive NeuroScience Inc. 59 Dr. Cauwenbergh 59 ImaginAb 59 Nutritional Metabolism